Literature DB >> 19545935

Serotype replacement in perspective.

Ron Dagan1.   

Abstract

An increase in the incidence of invasive pneumococcal disease (IPD) caused by non-vaccine serotypes (NVTs) (serotype replacement) has been observed since the introduction of the seven-valent pneumococcal conjugate vaccine (PCV7), primarily in the elderly, HIV-positive adults, and children with underlying medical conditions. In children aged <5 years, only a slight increase in replacement disease due to NVTs has been observed, but the relationship of changes in serotype carriage to replacement disease is not well understood. Predominant post-PCV7 NVTs include serotypes 15, 19A, and 33F, but the increasing antibiotic resistance of 19A is of particular concern in both vaccinated and unvaccinated populations.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19545935     DOI： 10.1016/j.vaccine.2009.06.004

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  32 in total

1.  Serological criteria and carriage measurement for evaluation of new pneumococcal vaccines.

Authors:  Nicola Principi; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Pediatric complicated pneumonia and pneumococcal serotype replacement: trends in hospitalized children pre and post introduction of routine vaccination with Pneumococcal Conjugate Vaccine (PCV7).

Authors:  Thea K Chibuk; Joan L Robinson; Dawn S Hartfield
Journal:  Eur J Pediatr       Date:  2010-04-10       Impact factor: 3.183

3.  Clonal distribution of common pneumococcal serotypes not included in the 7-valent conjugate vaccine (PCV7): marked differences between two ethnic populations in southern Israel.

Authors:  Nurith Porat; Rachel Benisty; Ronit Trefler; Noga Givon-Lavi; Ron Dagan
Journal:  J Clin Microbiol       Date:  2012-08-08       Impact factor: 5.948

4.  RrgB321, a fusion protein of the three variants of the pneumococcal pilus backbone RrgB, is protective in vivo and elicits opsonic antibodies.

Authors:  Carole Harfouche; Sara Filippini; Claudia Gianfaldoni; Paolo Ruggiero; Monica Moschioni; Silvia Maccari; Laura Pancotto; Letizia Arcidiacono; Bruno Galletti; Stefano Censini; Elena Mori; Marzia Giuliani; Claudia Facciotti; Elena Cartocci; Silvana Savino; Francesco Doro; Michele Pallaoro; Salvatore Nocadello; Giuseppe Mancuso; Mitch Haston; David Goldblatt; Michèle A Barocchi; Mariagrazia Pizza; Rino Rappuoli; Vega Masignani
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

5.  Influence of age, social patterns and nasopharyngeal carriage on antibodies to three conserved pneumococcal surface proteins (PhtD, PcpA and PrtA) in healthy young children.

Authors:  A Hagerman; K M Posfay-Barbe; S Grillet; M M Ochs; R H Brookes; D Greenberg; N Givon-Lavi; R Dagan; C-A Siegrist
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-18       Impact factor: 3.267

6.  Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in mice.

Authors:  Maria Leonor S Oliveira; Eliane N Miyaji; Daniela M Ferreira; Adriana T Moreno; Patricia C D Ferreira; Fernanda A Lima; Fernanda L Santos; Maria Aparecida Sakauchi; Célia S Takata; Hisako G Higashi; Isaías Raw; Flavia S Kubrusly; Paulo L Ho
Journal:  PLoS One       Date:  2010-05-27       Impact factor: 3.240

Review 7.  Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project.

Authors:  Hope L Johnson; Maria Deloria-Knoll; Orin S Levine; Sonia K Stoszek; Laura Freimanis Hance; Richard Reithinger; Larry R Muenz; Katherine L O'Brien
Journal:  PLoS Med       Date:  2010-10-05       Impact factor: 11.069

8.  Bacterial Density, Serotype Distribution and Antibiotic Resistance of Pneumococcal Strains from the Nasopharynx of Peruvian Children Before and After Pneumococcal Conjugate Vaccine 7.

Authors:  Christiane R Hanke; Carlos G Grijalva; Sopio Chochua; Mathias W Pletz; Claudia Hornberg; Kathryn M Edwards; Marie R Griffin; Hector Verastegui; Ana I Gil; Claudio F Lanata; Keith P Klugman; Jorge E Vidal
Journal:  Pediatr Infect Dis J       Date:  2016-04       Impact factor: 2.129

9.  Serotype distribution of Streptococcus pneumoniae in children with invasive diseases in Turkey: 2008-2014.

Authors:  Mehmet Ceyhan; Yasemin Ozsurekci; Nezahat Gürler; Lütfiye Öksüz; Sohret Aydemir; Sengul Ozkan; Serife Yuksekkaya; Melike Keser Emiroglu; Meral Gültekin; Akgün Yaman; Abdurrahman Kiremitci; Keramettin Yanık; Arzu Karli; Hatice Ozcinar; Faruk Aydin; Gulcin Bayramoglu; Yasemin Zer; Zeynep Gulay; Efgan Dogan Gayyurhan; Mustafa Gül; Cüneyt Özakın; Hüseyin Güdücüoğlu; Duygu Perçin; Nezahat Akpolat; Candan Ozturk; Yıldız Camcıoğlu; Eda Karadağ Öncel; Melda Çelik; Laser Şanal; Hakan Uslu
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

10.  Epidemiological Markers for Interactions Among Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Upper Respiratory Tract Carriage.

Authors:  Joseph A Lewnard; Noga Givon-Lavi; Amit Huppert; Melinda M Pettigrew; Gili Regev-Yochay; Ron Dagan; Daniel M Weinberger
Journal:  J Infect Dis       Date:  2015-12-23       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.